Search results
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga· 4 days agoThursday, Moderna Inc MRNA reported a first-quarter EPS loss of $(3.07), down from an income of...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 4 days agoThis is a significant decline when compared to product sales of $1.83 billion in the year-ago...
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline Amid Strategic Shifts
GuruFocus.com via Yahoo Finance· 4 days agoModerna's programs cover infectious diseases, oncology, cardiovascular diseases, and rare genetic...
Why Africa is facing an uphill battle to make its own vaccines
The Telegraph via Yahoo News· 5 days agoThe continent was in dire need of its own production capabilities. As the pandemic raged, in March...
Why Moderna Stock Blasted 13% Higher Today
Motley Fool via Yahoo Finance· 4 days agoThe Spikevax story is over, but... Barring a renewed Covid surge -- fingers crossed! -- there isn't much future in Spikevax. Yet as ever, Moderna...
Moderna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoModerna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript May 2, 2024 Moderna, Inc. beats...
Moderna Results Beat Estimates as Company Prepares for RSV Shot Launch
Barrons.com· 5 days agoThe biotech company used revenue from its Covid-19 vaccine to finance other new products.Read the...
Moderna reports $1.2bn net loss in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 4 days agoNet product sales plummeted by 91% compared to Q1 2023. This downturn aligns with the expected transition to a seasonal market for Covid-19 vaccines....
Moderna Stock Rises on Vaccine Launch Target, Above-Consensus 1Q
Market Watch· 4 days agoBy Dean Seal Shares of Moderna rose after the company set a fall target date for the launch of its next vaccine and posted better first-quarter results than...
Royal Bank of Canada Increases Moderna (NASDAQ:MRNA) Price Target to $135.00
ETF DAILY NEWS· 2 days agoModerna (NASDAQ:MRNA – Get Free Report) had its target price lifted by Royal Bank of Canada from $125.00 to $135.00 in a report issued on Friday, Benzinga reports. Royal Bank ...